A

Artrya Ltd
ASX:AYA

Watchlist Manager
Artrya Ltd
ASX:AYA
Watchlist
Price: 3.45 AUD -1.43% Market Closed
Market Cap: 545.4m AUD

Profitability Summary

Artrya Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Artrya Ltd

Revenue
28k AUD
Operating Expenses
-16.6m AUD
Operating Income
-16.6m AUD
Other Expenses
212k AUD
Net Income
-16.4m AUD

Margins Comparison
Artrya Ltd Competitors

Country Company Market Cap Operating
Margin
Net
Margin
AU
Artrya Ltd
ASX:AYA
545.4m AUD
-59 350%
-58 593%
US
Veeva Systems Inc
NYSE:VEEV
39.8B USD
29%
28%
US
Cerner Corp
LSE:0R00
31.3B USD
13%
10%
AU
Pro Medicus Ltd
ASX:PME
26B AUD
75%
52%
JP
M3 Inc
TSE:2413
1.5T JPY
21%
13%
US
Doximity Inc
NYSE:DOCS
8.6B USD
40%
41%
US
Waystar Holding Corp
NASDAQ:WAY
6B USD
23%
11%
SE
Sectra AB
STO:SECT B
52.9B SEK
-19%
27%
US
Inspire Medical Systems Inc
NYSE:INSP
4B USD
4%
5%
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
282.2B INR
25%
18%
US
Vocera Communications Inc
F:V00
2.4B EUR
0%
-4%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Artrya Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Artrya Ltd
ASX:AYA
545.4m AUD
-86%
-77%
-85%
-153%
US
Veeva Systems Inc
NYSE:VEEV
39.8B USD
14%
12%
14%
49%
US
Cerner Corp
LSE:0R00
31.3B USD
14%
8%
12%
10%
AU
Pro Medicus Ltd
ASX:PME
26B AUD
52%
39%
64%
101%
JP
M3 Inc
TSE:2413
1.5T JPY
11%
8%
13%
13%
US
Doximity Inc
NYSE:DOCS
8.6B USD
25%
21%
23%
64%
US
Waystar Holding Corp
NASDAQ:WAY
6B USD
4%
2%
5%
4%
SE
Sectra AB
STO:SECT B
52.9B SEK
32%
17%
-21%
-13%
US
Inspire Medical Systems Inc
NYSE:INSP
4B USD
7%
6%
5%
8%
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
282.2B INR N/A N/A N/A N/A
US
Vocera Communications Inc
F:V00
2.4B EUR
-5%
-2%
0%
0%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less